Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones.

NCT03630926 · clinicaltrials.gov ↗

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Benign Prostatic Hypertrophy
Bladder Stones
Kidney Stones

Interventions

DIAGNOSTIC_TEST: NV-VPAC1 PCa Urine Diagnostic Test

Sponsor

Intermountain Health Care, Inc.

Collaborators

[object Object]